issin Inc. (Headquarters: Bunkyo-ku, Tokyo; Representative Director: Tao Cheng; hereinafter "issin"), a healthcare startup originating from the University of Tokyo, is pleased to announce that its Representative Director and CEO, Tao Cheng, will be a speaker at a lecture hosted by Keio University School of Medicine as part of the "11th Health and Medical Venture Award." The lecture will be held on Friday, July 3, 2026, with the theme "How to Make Pre-symptomatic Health Measures a Business? - Thinking about Healthcare Business from Field Needs and Social Implementation." Participation is free of charge and open to both students and working professionals. Event Overview At this lecture, Masaya Sawafuji, Deputy Director of the Keio University Center for Preventive Medicine, and Tao Cheng, Representative Director and CEO of issin, will speak. They will discuss field needs and challenges in the pre-symptomatic health measures domain, strategies for ensuring continuous use of healthcare services, and perspectives on social implementation as a business, from both field and commercialization viewpoints. Event Name 11th Health and Medical Venture Award Lecture for Students "How to Make Pre-symptomatic Health Measures a Business? -- Thinking about Healthcare Business from Field Needs and Social Implementation" Date and Time Friday, July 3, 2026, 18:00 - 20:00 *Closing remarks and networking reception are scheduled from 19:35 to 20:00. Participation Fee Free Venue CRIK Shinanomachi Community Space Target Audience Those interested in the medical and healthcare fields Those considering applying for the Health and Medical Venture Award Those interested in pre-symptomatic health measures, preventive medicine, and healthcare businesses (Open to both students and working professionals) Event Content and Schedule (Tentative) 18:00 - 18:05 Opening Remarks 18:05 - 18:35 Lecture and Q&A by Masaya Sawafuji (Deputy Director, Keio University Center for Preventive Medicine) 18:35 - 19:05 Le